The global market for BGMS (Blood Glucose Monitoring System) was estimated to be worth US$ 16588 million in 2024 and is forecast to a readjusted size of US$ 32002 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
A blood glucose monitoring system is a medical device or system used to measure and track blood glucose (sugar) levels in individuals, especially those with diabetes. It includes traditional self-monitoring blood glucose (SMBG) devices using test strips and glucometers, as well as advanced continuous glucose monitoring (CGM) systems that provide real-time data through wearable sensors. These systems help patients and healthcare providers manage blood sugar levels, adjust medications, and prevent complications like hypoglycemia or hyperglycemia.
The blood glucose monitoring system market is primarily driven by the global rise in diabetes prevalence, fueled by aging populations, sedentary lifestyles, and poor dietary habits. Growing awareness of the importance of glucose control, along with increased healthcare spending and government support for chronic disease management, is boosting demand for both continuous glucose monitors (CGMs) and self-monitoring blood glucose (SMBG) devices. Technological advancements such as smartphone connectivity, real-time alerts, and non-invasive sensors are further expanding the market, especially among younger and tech-savvy patients.
Despite strong demand, the market faces several challenges. High device costs, especially for CGMs and advanced digital platforms, limit access in low- and middle-income countries. In addition, user adherence and accuracy concerns-particularly with improper device usage or calibration errors-can impact clinical outcomes and patient trust. Regulatory hurdles, reimbursement issues, and the need for continuous innovation to differentiate in a competitive market also pose significant obstacles for manufacturers.
This report aims to provide a comprehensive presentation of the global market for BGMS (Blood Glucose Monitoring System), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of BGMS (Blood Glucose Monitoring System) by region & country, by Type, and by Application.
The BGMS (Blood Glucose Monitoring System) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BGMS (Blood Glucose Monitoring System).
Market Segmentation
By Company
- Abbott
- Roche
- Lifescan
- Ascensia
- ARKRAY
- Sinocare
- I-SENS
- Terumo
- B. Braun
- Acon
- Yicheng
- Omron
- SD Biosensor
- 77 Elektronika
- Yuwell
- Osang Healthcare
- AgaMatrix
- Senseonics Holdings
- Sinomedisite
- Vivacheck
- Empecs
- Andon
- Dexcom
- Medtronic
- Meiqi Medical
- Medtrum Technologies
- MicroTech Medical
Segment by Type
- Blood Glucose Test Strips
- Blood Glucose Meter
- CGM
Segment by Application
By Region
- North America
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of BGMS (Blood Glucose Monitoring System) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of BGMS (Blood Glucose Monitoring System) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of BGMS (Blood Glucose Monitoring System) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 BGMS (Blood Glucose Monitoring System) Product Introduction
- 1.2 Global BGMS (Blood Glucose Monitoring System) Market Size Forecast (2020-2031)
- 1.3 BGMS (Blood Glucose Monitoring System) Market Trends & Drivers
- 1.3.1 BGMS (Blood Glucose Monitoring System) Industry Trends
- 1.3.2 BGMS (Blood Glucose Monitoring System) Market Drivers & Opportunity
- 1.3.3 BGMS (Blood Glucose Monitoring System) Market Challenges
- 1.3.4 BGMS (Blood Glucose Monitoring System) Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global BGMS (Blood Glucose Monitoring System) Players Revenue Ranking (2024)
- 2.2 Global BGMS (Blood Glucose Monitoring System) Revenue by Company (2020-2025)
- 2.3 Key Companies BGMS (Blood Glucose Monitoring System) Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies BGMS (Blood Glucose Monitoring System) Product Offered
- 2.5 Key Companies Time to Begin Mass Production of BGMS (Blood Glucose Monitoring System)
- 2.6 BGMS (Blood Glucose Monitoring System) Market Competitive Analysis
- 2.6.1 BGMS (Blood Glucose Monitoring System) Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by BGMS (Blood Glucose Monitoring System) Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BGMS (Blood Glucose Monitoring System) as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 Blood Glucose Test Strips
- 3.1.2 Blood Glucose Meter
- 3.1.3 CGM
- 3.2 Global BGMS (Blood Glucose Monitoring System) Sales Value by Type
- 3.2.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Type (2020-2031)
- 3.2.3 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Hospital
- 4.1.2 Household
- 4.2 Global BGMS (Blood Glucose Monitoring System) Sales Value by Application
- 4.2.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Application (2020-2031)
- 4.2.3 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region
- 5.1.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2020-2025)
- 5.1.3 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2026-2031)
- 5.1.4 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.2.2 North America BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.3.2 Europe BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.4.2 Asia Pacific BGMS (Blood Glucose Monitoring System) Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.5.2 South America BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.6.2 Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.3.2 United States BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.4.2 Europe BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.5.2 China BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.6.2 Japan BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.7.2 South Korea BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.8.2 Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.9.2 India BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Abbott
- 7.1.1 Abbott Profile
- 7.1.2 Abbott Main Business
- 7.1.3 Abbott BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.1.4 Abbott BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.1.5 Abbott Recent Developments
- 7.2 Roche
- 7.2.1 Roche Profile
- 7.2.2 Roche Main Business
- 7.2.3 Roche BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.2.4 Roche BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.2.5 Roche Recent Developments
- 7.3 Lifescan
- 7.3.1 Lifescan Profile
- 7.3.2 Lifescan Main Business
- 7.3.3 Lifescan BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.3.4 Lifescan BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.3.5 Lifescan Recent Developments
- 7.4 Ascensia
- 7.4.1 Ascensia Profile
- 7.4.2 Ascensia Main Business
- 7.4.3 Ascensia BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.4.4 Ascensia BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.4.5 Ascensia Recent Developments
- 7.5 ARKRAY
- 7.5.1 ARKRAY Profile
- 7.5.2 ARKRAY Main Business
- 7.5.3 ARKRAY BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.5.4 ARKRAY BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.5.5 ARKRAY Recent Developments
- 7.6 Sinocare
- 7.6.1 Sinocare Profile
- 7.6.2 Sinocare Main Business
- 7.6.3 Sinocare BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.6.4 Sinocare BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.6.5 Sinocare Recent Developments
- 7.7 I-SENS
- 7.7.1 I-SENS Profile
- 7.7.2 I-SENS Main Business
- 7.7.3 I-SENS BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.7.4 I-SENS BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.7.5 I-SENS Recent Developments
- 7.8 Terumo
- 7.8.1 Terumo Profile
- 7.8.2 Terumo Main Business
- 7.8.3 Terumo BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.8.4 Terumo BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.8.5 Terumo Recent Developments
- 7.9 B. Braun
- 7.9.1 B. Braun Profile
- 7.9.2 B. Braun Main Business
- 7.9.3 B. Braun BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.9.4 B. Braun BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.9.5 B. Braun Recent Developments
- 7.10 Acon
- 7.10.1 Acon Profile
- 7.10.2 Acon Main Business
- 7.10.3 Acon BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.10.4 Acon BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.10.5 Acon Recent Developments
- 7.11 Yicheng
- 7.11.1 Yicheng Profile
- 7.11.2 Yicheng Main Business
- 7.11.3 Yicheng BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.11.4 Yicheng BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.11.5 Yicheng Recent Developments
- 7.12 Omron
- 7.12.1 Omron Profile
- 7.12.2 Omron Main Business
- 7.12.3 Omron BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.12.4 Omron BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.12.5 Omron Recent Developments
- 7.13 SD Biosensor
- 7.13.1 SD Biosensor Profile
- 7.13.2 SD Biosensor Main Business
- 7.13.3 SD Biosensor BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.13.4 SD Biosensor BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.13.5 SD Biosensor Recent Developments
- 7.14 11 Elektronika
- 7.14.1 12 Elektronika Profile
- 7.14.2 14 Elektronika Main Business
- 7.14.3 16 Elektronika BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.14.4 18 Elektronika BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.14.5 19 Elektronika Recent Developments
- 7.15 Yuwell
- 7.15.1 Yuwell Profile
- 7.15.2 Yuwell Main Business
- 7.15.3 Yuwell BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.15.4 Yuwell BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.15.5 Yuwell Recent Developments
- 7.16 Osang Healthcare
- 7.16.1 Osang Healthcare Profile
- 7.16.2 Osang Healthcare Main Business
- 7.16.3 Osang Healthcare BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.16.4 Osang Healthcare BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.16.5 Osang Healthcare Recent Developments
- 7.17 AgaMatrix
- 7.17.1 AgaMatrix Profile
- 7.17.2 AgaMatrix Main Business
- 7.17.3 AgaMatrix BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.17.4 AgaMatrix BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.17.5 AgaMatrix Recent Developments
- 7.18 Senseonics Holdings
- 7.18.1 Senseonics Holdings Profile
- 7.18.2 Senseonics Holdings Main Business
- 7.18.3 Senseonics Holdings BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.18.4 Senseonics Holdings BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.18.5 Senseonics Holdings Recent Developments
- 7.19 Sinomedisite
- 7.19.1 Sinomedisite Profile
- 7.19.2 Sinomedisite Main Business
- 7.19.3 Sinomedisite BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.19.4 Sinomedisite BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.19.5 Sinomedisite Recent Developments
- 7.20 Vivacheck
- 7.20.1 Vivacheck Profile
- 7.20.2 Vivacheck Main Business
- 7.20.3 Vivacheck BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.20.4 Vivacheck BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.20.5 Vivacheck Recent Developments
- 7.21 Empecs
- 7.21.1 Empecs Profile
- 7.21.2 Empecs Main Business
- 7.21.3 Empecs BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.21.4 Empecs BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.21.5 Empecs Recent Developments
- 7.22 Andon
- 7.22.1 Andon Profile
- 7.22.2 Andon Main Business
- 7.22.3 Andon BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.22.4 Andon BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.22.5 Andon Recent Developments
- 7.23 Dexcom
- 7.23.1 Dexcom Profile
- 7.23.2 Dexcom Main Business
- 7.23.3 Dexcom BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.23.4 Dexcom BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.23.5 Dexcom Recent Developments
- 7.24 Medtronic
- 7.24.1 Medtronic Profile
- 7.24.2 Medtronic Main Business
- 7.24.3 Medtronic BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.24.4 Medtronic BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.24.5 Medtronic Recent Developments
- 7.25 Meiqi Medical
- 7.25.1 Meiqi Medical Profile
- 7.25.2 Meiqi Medical Main Business
- 7.25.3 Meiqi Medical BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.25.4 Meiqi Medical BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.25.5 Meiqi Medical Recent Developments
- 7.26 Medtrum Technologies
- 7.26.1 Medtrum Technologies Profile
- 7.26.2 Medtrum Technologies Main Business
- 7.26.3 Medtrum Technologies BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.26.4 Medtrum Technologies BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.26.5 Medtrum Technologies Recent Developments
- 7.27 MicroTech Medical
- 7.27.1 MicroTech Medical Profile
- 7.27.2 MicroTech Medical Main Business
- 7.27.3 MicroTech Medical BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.27.4 MicroTech Medical BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.27.5 MicroTech Medical Recent Developments
8 Industry Chain Analysis
- 8.1 BGMS (Blood Glucose Monitoring System) Industrial Chain
- 8.2 BGMS (Blood Glucose Monitoring System) Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 BGMS (Blood Glucose Monitoring System) Sales Model
- 8.5.2 Sales Channel
- 8.5.3 BGMS (Blood Glucose Monitoring System) Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.2 Author Details
- 10.3 Disclaimer